PER 4.65% 9.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-581

  1. 265 Posts.
    lightbulb Created with Sketch. 499
    Let's see what they're going to update to PPMD...Parent Project Muscular Dystrophy has invited Sarepta Therapeutics to present details of the EMBARK clinical trial (SRP-9001-301).

    https://hotcopper.com.au/data/attachments/3680/3680662-4b9ad591788014079be3e3acfb9d8c67.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.